MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字H20213571

July 6, 2021

Drug Information

盐酸厄洛替尼片

片剂

0.15g(按C22H23N3O4计)

化学药品

July 6, 2021

Company Information

Applicant Company

深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区

Manufacturing Company

深圳市坪山区龙田街道大工业区规划五路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath